CTLA4 and melanoma: Variable levels of CTLA-4 expression were detected in circulating and tumor-infiltrating NK cells and non-NK cell ILC in melanoma [160], hepatocellular carcinoma [49], breast and gastrointestinal [124] cancers, with higher levels found in tumor-infiltrating ILC compared to circulating cells.